Published in Am J Cardiol on November 01, 1971
Selective blockade of adrenoceptive beta receptors in the heart. Br J Pharmacol Chemother (1968) 14.80
A mobile intensive-care unit in the management of myocardial infarction. Lancet (1967) 13.73
Comparison of some properties of pronethalol and propranolol. Br J Pharmacol Chemother (1965) 4.71
Cardiac arrest after myocardial infarction. Lancet (1966) 4.59
Comparison of the effects of I.C.I. 50172 and propranolol on the cardiovascular responses to adrenaline, isoprenaline and exercise. Br J Pharmacol (1968) 4.20
Acute phase of myocardial infarction. Lancet (1971) 4.05
The pharmacology of beta sympathetic blockade. Am J Cardiol (1966) 3.96
Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker. Clin Pharmacol Ther (1976) 3.16
Optical isomers of propranolol. Nature (1966) 3.09
Management of ventricular fibrillation outside hospital. Lancet (1969) 3.07
Prognosis after recovery from ventricular fibrillation complicating ischaemic heart-disease. Lancet (1967) 2.97
The cardio-toxicity of isoprenaline during hypoxia. Br J Pharmacol (1969) 2.94
The clinical pharmacology of mexiletine. Br J Clin Pharmacol (1978) 2.56
Controlled trial of propranolol in thyrotoxicosis. Lancet (1969) 2.54
The effect of propranolol on the cardiovascular responses to isoprenaline, adrenaline and noradrenaline in the anaesthetized dog. Br J Pharmacol Chemother (1966) 2.52
Autonomic disturbance at onset of acute myocardial infarction. Br Med J (1972) 2.50
Cardio-selective beta-blockade. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1968) 2.33
Laparoscopic dismembered pyeloplasty: 50 consecutive cases. BJU Int (2001) 2.21
The effect of Kö 1173, a new anticonvulsant agent on experimental cardiac arrhythmias. Br J Pharmacol (1972) 2.11
Incidence, significance, and management of early bradyarrhythmia complicating acute myocardial infarction. Lancet (1968) 2.08
Long-term prognosis following ventricular fibrillation in acute ischaemic heart disease. Br Med J (1970) 1.99
The clinical pharmacology of beta adrenergic blocking drugs. J R Coll Physicians Lond (1976) 1.94
National Poisons Information Services: report and comment 1980. Br Med J (Clin Res Ed) (1981) 1.91
Oral mexiletine in high-risk patients after myocardial infarction. Lancet (1981) 1.91
The peripheral vascular effects of propranolol and related compounds. Br J Pharmacol Chemother (1967) 1.87
The effect of experimental cardiac arrhythmias of a new anticonvulsant agent, Kö 1173, and its comparison with phenytoin and procainamide. Br J Pharmacol (1970) 1.81
Blood levels of practolol after oral and parenteral administration and their relationship to exercise heart rate. Clin Pharmacol Ther (1974) 1.81
Influence of intrinsic sympathomimetic activity and cardioselectivity on beta adrenoceptor blockade. Clin Pharmacol Ther (1977) 1.77
Observations on the efficacy and pharmacokinetics of sotalol after oral administration. Eur J Clin Pharmacol (1976) 1.71
Mexiletine (Kö 1173) in the management of ventricular dysrhythmias. Lancet (1973) 1.68
Diffuse interstitial pneumonitis. Clinicopathologic correlations in 20 patients treated with prednisone/azathioprine. Am J Med (1978) 1.67
Some pharmacological properties of a new adrenergic beta-receptor antagonist. Nature (1966) 1.66
Effects of the beta 2-adrenoceptor antagonist ICI 118,551 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man. Br J Clin Pharmacol (1985) 1.65
Propranolol and the utilization of radioiodine by the human thyroid gland. Acta Endocrinol (Copenh) (1969) 1.63
Effect of propranolol on arrhythmias following coronary artery occlusion in dogs. Cardiovasc Res (1967) 1.61
Neonatal thyrotoxicosis treated with propranolol. Arch Dis Child (1974) 1.59
Comparison of the activity and plasma levels of oxprenolol, slow release oxprenolol, long acting propranolol and sotalol. Eur J Clin Pharmacol (1980) 1.57
Comparison of the efficacy and pharmacokinetics of conventional propranolol and a long acting preparation of propranolol. Br J Clin Pharmacol (1980) 1.55
Electrical requirements for ventricular defibrillation. Br Med J (1975) 1.53
Stimulation of adrenergic beta-receptors by orciprenaline. Br Med J (1967) 1.52
Mobile coronary care. Chest (1970) 1.50
Current required for ventricular defibrillation. Br Med J (1979) 1.46
Frequency analysis of ventricular fibrillation and resuscitation success. Q J Med (1992) 1.46
Debendox and congenital malformations in Northern Ireland. Br Med J (1980) 1.46
Management of complete heart block complicating acute myocardial infarction. Lancet (1967) 1.45
Pre-hospital coronary care. The mobile coronary care unit. Am J Cardiol (1969) 1.44
Clinical pharmacology methodology: introduction. Br J Clin Pharmacol (1978) 1.39
Comparison of the effect of propranolol, lignocaine, and other drugs on normal and raised intraocular pressure in man. Am J Ophthalmol (1971) 1.37
Spectrophotofluorometric and gas-liquid chromatographic methods for the estimation of mexiletine (Kö 1173) in plasma and urine. J Pharm Pharmacol (1973) 1.36
Beliefs about Papanicolaou smears and compliance with Papanicolaou smear follow-up in adolescents. Arch Pediatr Adolesc Med (1999) 1.33
Duration of action of beta-blocking drugs. Br Med J (1973) 1.33
Effects of alinidine, a novel bradycardic agent, on heart rate and blood pressure in man. J Cardiovasc Pharmacol (1982) 1.32
Propranolol and iodine-131 in the management of thyrotoxicosis. Lancet (1968) 1.29
Effects of partial extraction of troponin complex upon the tension-pCa relation in rabbit skeletal muscle. Further evidence that tension development involves cooperative effects within the thin filament. J Gen Physiol (1986) 1.29
St-segment displacement and early hospital discharge in acute myocardial infarction. Lancet (1973) 1.28
Stimulation of gastrin release by catecholamines. Lancet (1972) 1.26
Arrhythmias in the first hours of acute myocardial infarction. Prog Cardiovasc Dis (1981) 1.26
Hereditary alpha-1-antitrypsin deficiency. N Engl J Med (1968) 1.26
Comparison of the effects of propranolol and MJ 1999 on cardiac beta-adrenoceptors in man. Br J Pharmacol (1970) 1.24
Effects on exercise tachycardia during forty-eight hours of a series of doses of atenolol, sotalol, and metoprolol. Clin Pharmacol Ther (1981) 1.23
Breast cancer resistance protein is localized at the plasma membrane in mitoxantrone- and topotecan-resistant cell lines. Cancer Res (2000) 1.21
Using a pharmacogenomic algorithm to guide the treatment of depression. Transl Psychiatry (2012) 1.19
Long-term oral antiarrhythmic therapy with mexiletine. Br Heart J (1978) 1.18
Effects of the myocardial-selective alpha 1-adrenoceptor antagonist UK-52046 and atenolol, alone and in combination, on experimental cardiac arrhythmias in dogs. Br J Pharmacol (1988) 1.17
Sources of control over schedule-induced drinking produced by second-order schedules of reinforcement. Physiol Behav (1977) 1.17
Cardiovascular effects of alinidine and propranolol alone and in combination with hydralazine in normal man. Br J Clin Pharmacol (1983) 1.16
Is Apaf-1 expression frequently abrogated in melanoma? Cell Death Differ (2005) 1.15
Schedule-induced drinking as a function of percentage reinforcement. J Exp Anal Behav (1975) 1.14
Correlation of reduction of exercise heart rate with blood levels of atenolol after oral and intravenous administration. Postgrad Med J (1977) 1.13
Manning mobile intensive-care units. Lancet (1967) 1.12
Schedule-induced drinking as a function of interreinforcement interval in the rhesus monkey. J Exp Anal Behav (1976) 1.11
Is verapamil a beta-blocker? Lancet (1968) 1.11
The role of the thyroid in the control of heart-rate. Lancet (1968) 1.10
The development of mexiletine in the management of ventricular dysrhythmias. Postgrad Med J (1977) 1.09
Transthoracic ventricular defibrillation in adults. Br Med J (1977) 1.09
The pharmacokinetics of vincristine in man: reduced drug clearance associated with raised serum alkaline phosphatase and dose-limited elimination. Cancer Chemother Pharmacol (1982) 1.08
Psychiatric pharmacogenomics predicts health resource utilization of outpatients with anxiety and depression. Transl Psychiatry (2013) 1.07
Alinidine reduces heart-rate without blockade of beta-adrenoceptors. Lancet (1981) 1.06
Symposium on arteriosclerotic heart disease. The prehospital phase of treatment for myocardial infarction. Geriatrics (1972) 1.05
Effects of lignocaine and propranolol on experimental cardiac arrhythmias. Br J Pharmacol (1971) 1.04
Rounded biphasic waveform reduces energy requirements for transvenous catheter cardioversion of atrial fibrillation and flutter. Pacing Clin Electrophysiol (1997) 1.03
Transthoracic ventricular defibrillation in the adult. Med Instrum (1978) 1.03
Characterization of the beta-adrenoreceptors which mediate the isoprenaline-induced changes in finger tremor and cardiovascular function in man. Eur J Clin Pharmacol (1988) 1.03
Death and damage caused by multiple direct current shocks: studies in an animal model. Eur Heart J (1988) 1.02
Effects of ICI 141,292 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man. Br J Clin Pharmacol (1986) 1.01
The effect of the dextro isomer of propranolol on sinus rate and cardiac arrhythmias. Am Heart J (1968) 1.01
Heart-rate changes during movement of patients with acute myocardial infarction. Lancet (1974) 1.00
The selectivity of xamoterol, prenalterol, and salbutamol as assessed by their effects in the presence and absence of ICI 118,551. J Cardiovasc Pharmacol (1988) 1.00
Comparison of the effects of isoprenaline, orciprenaline, salbutamol and isoetharine on the cardiovascular system of anaesthetized dogs. Br J Pharmacol (1971) 1.00
The properties of beta-adrenoceptor antagonists. Postgrad Med J (1976) 1.00
Observation on the efficacy and pharmacokinetics of betaxolol (SL 75212), a cardioselective beta-adrenoceptor blocking drug. Br J Clin Pharmacol (1981) 1.00
The long term efficacy of a hardjo-pomona vaccine in preventing leptospiruria in cattle exposed to natural challenge with Leptospira interrogans serovar hardjo. Aust Vet J (1984) 0.99
Mariner IV Photography of Mars: Initial Results. Science (1965) 0.98
Diagnosis and results of surgery in renovascular hypertension. Lancet (1966) 0.98
Suppression of ventricular arrhythmias after coronary artery ligation by pinacidil, a vasodilator drug. J Cardiovasc Pharmacol (1985) 0.98